@article{Alnajjar2020,
title = {Personalized Robot Interventions for Autistic Children: An Automated Methodology for Attention Assessment},
author = {F Alnajjar and M Cappuccio and A Renawi and O Mubin and C K Loo},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081653497&doi=10.1007%2fs12369-020-00639-8&partnerID=40&md5=99d36c26b54c3f23ebb13499387b859a},
doi = {10.1007/s12369-020-00639-8},
issn = {18754791},
year = {2020},
date = {2020-01-01},
journal = {International Journal of Social Robotics},
publisher = {Springer},
abstract = {We propose a robot-mediated therapy and assessment system for children with autism spectrum disorder (ASD) of mild to moderate severity and minimal verbal capabilities. The objectives of the robot interaction sessions is to improve the academic capabilities of ASD patients by increasing the length and the quality of their attention. The system uses a NAO robot and an added mobile display to present emotional cues and solicit appropriate emotional responses. The interaction is semi-autonomous with minimal human intervention.Interaction occurs within an adaptive dynamic scenario composed of 13 sections. The scenario allows adaptive customization based on the attention score history of each patient. The attention score is autonomously generated by the system and depends on face attention and joint attention cues and sound responses. The scoring system allows us to prove that the customized interaction system increases the engagement and attention capabilities of ASD patients.After performing a pilot study, involving 6 ASD children, out of a total of 11 considered in the clinical setup, we conducted a long-term study. This study empirically proves that the proposed assessment system represents the attention state of the patient with 82.4% accuracy. © 2020, Springer Nature B.V.},
note = {cited By 0},
keywords = {Assessment, Attention, Autism, Children with Autism, Diseases, Emotion, Emotional Response, Interaction Systems, Robotics, Robots, Therapy},
pubstate = {published},
tppubtype = {article}
}

@article{Alwi2015393,
title = {Clinical application of sensory integration therapy for children with autism},
author = {N Alwi and D Harun and J H Leonard},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940898525&doi=10.1016%2fj.ejmhg.2015.05.009&partnerID=40&md5=5548f0db22520a480f09da9aaf4c872e},
doi = {10.1016/j.ejmhg.2015.05.009},
issn = {11108630},
year = {2015},
date = {2015-01-01},
journal = {Egyptian Journal of Medical Human Genetics},
volume = {16},
number = {4},
pages = {393-394},
publisher = {Egyptian Society of Human Genetics},
note = {cited By 1},
keywords = {Autism, Disease Severity, Groups by Age, Human, Letter, Motor Performance, Outcome Assessment, Sensorimotor Integration, Therapy, Therapy Effect, Treatment Indication, Treatment Response},
pubstate = {published},
tppubtype = {article}
}

@article{Patel2010169,
title = {Reducing the treatment gap for mental disorders: A WPA survey},
author = {V Patel and M Maj and A J Flisher and M J De Silva and M Koschorke and M Prince and R Tempier and M B Riba and M Sanchez and F D Campodonico and L Risco and L Gask and H Wahlberg and M Roca and D Lecic-Tosevski and A Soghoyan and D Moussaoui and C Baddoura and J Adeyemi and S Rataemane and S A Jalili and E Mohandas and N Shinfuku and J Freidin and J C Stagnaro and I J Puig and K Kirkby and M Musalek and N Ismayilov and G Rabbani and S Harvey and B Sabbe and N Noya-Tapia and M Burgic-Radmanovic and L A Hetem and F Vasconcellos and J Maass and C Miranda and N Papaneophytou and J Raboch and A Fink-Jensen and A Okasha and J Korkeila and J D Guelfi and F Schneider and S Ohene and G Christodoulou and C R Soldatos and S K E Q Barrera and M Mendoza and R A Kallivayalil and S S Gudarzi and M R Lafta and M Bassi and M Clerici and R Gibson and T Kojima and S Nurmagambetova and S -C Cho and T Kadyrova and N Mikati and S Bajraktarov and T H Yen and B Ayushjav and L I Stevovic and J S S Molina and O Gureje and J O Johannessen and H R Chaudhry and B Al-Ashhab and A Araszkiewicz and D Prelipceanu and V Krasnov and A Bogdanov and M Jasovic-Gasic and L Vavrusova and P Pregelj and A F Liria and A Abdelrahman and P Udomratn and H Ulas and P Gokaip and F N Kigozi and G Richardson},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-79851492757&doi=10.1002%2fj.2051-5545.2010.tb00305.x&partnerID=40&md5=ebf47e1e84f22271aea10a73c93e9892},
doi = {10.1002/j.2051-5545.2010.tb00305.x},
issn = {17238617},
year = {2010},
date = {2010-01-01},
journal = {World Psychiatry},
volume = {9},
number = {3},
pages = {169-176},
publisher = {Blackwell Publishing Ltd},
abstract = {The treatment gap for people with mental disorders exceeds 50% in all countries of the world, approaching astonishingly high rates of 90% in the least resourced countries. We report the findings of the first systematic survey of leaders of psychiatry in nearly 60 countries on the strategies for reducing the treatment gap. We sought to elicit the views of these representatives on the roles of different human resources and health care settings in delivering care and on the importance of a range of strategies to increase the coverage of evidence-based treatments for priority mental disorders for each demographic stage (childhood, adolescence, adulthood and old age). Our findings clearly indicate three strategies for reducing the treatment gap: increasing the numbers of psychiatrists and other mental health professionals; increasing the involvement of a range of appropriately trained non-specialist providers; and the active involvement of people affected by mental disorders. This is true for both high income and low/middle income countries, though relatively of more importance in the latter. We view this survey as a critically important first step in ascertaining the position of psychiatrists, one of the most influential stakeholder communities in global mental health, in addressing the global challenge of scaling up mental health services to reduce the treatment gap.},
note = {cited By 127},
keywords = {Anxiety Disorder, Article, Atomoxetine, Atypical Antipsychotic Agent, Autism, Benzodiazepine, Bipolar Disorder, Central Nervous System Stimulants, Cholinesterase Inhibitor, Cognitive Therapy, Community Mental Health Center, Conduct Disorder, Cost Effectiveness Analysis, Dementia, Depression, Evidence-based Practice, Family, Family Therapy, Haloperidol, Health Care, Health Care Access, Health Care Delivery, Health Care Personnel, Health Practitioner, Health Survey, Help Seeking Behavior, Home Mental Health Care, Human, Hyperkinesia, Long Term Care, Lowest Income Group, Mental Deficiency, Mental Disease, Mental Health, Mental Health Care, Mental Health Service, Nootropic Agent, Open Ended Questionnaire, Outcome Assessment, Patient Compliance, Personality Disorder, Practice Guideline, Priority Journal, Psychiatry, Psychoeducation, Psychotherapy, Schizophrenia, Serotonin Noradrenalin Reuptake Inhibitor, Serotonin Uptake Inhibitor, Substance Abuse, Therapy, Therapy Delay, Tricyclic Antidepressant Agent, World Health Organization},
pubstate = {published},
tppubtype = {article}
}